中文 | English
Return
Total: 7 , 1/1
Show Home Prev Next End page: GO
Author:( Liumeng YANG)

2.Establishment and optimization of a method for screening HIV-1 integrase 3′-processing inhibitor

Cuilin LU ; Xuan ZHANG ; Jinbiao ZHAN ; Liumeng YANG ; Yongtang ZHENG

Chinese Pharmacological Bulletin 2014;(10):1469-1473

3.Determination of the Concentrations of Ceftriaxone in Blood and Bile of Patients During Perioperative Period

Yuqin YIN ; Liumeng YANG ; Guili XU ; Jing ZOU

China Pharmacy 2001;0(07):-

4.Screening of Active Compounds Against HIV-1 Reverse Transcriptase Based on Molecular Docking

Shushen JI ; Xinan HUANG ; Ronghua LUO ; Liumeng YANG ; Yongtang ZHENG ; Linchun FU

Journal of Guangzhou University of Traditional Chinese Medicine 2015;(4):725-728

6.Study on Vitro Anti-HIV-1 Activity ofTaiqi PeiyuanGranules

Xiulan MA ; Jianping MA ; Ying ZHANG ; Aihemaiti ABUDUREYIMU ; Jingru LI ; Lin ZENG ; Yongtang ZHENG ; Liumeng YANG ; Lixue MA

Chinese Journal of Information on Traditional Chinese Medicine 2016;23(4):61-63

7.Synthesis and biological evaluation of a series of 2-(((5-akly/aryl-1-pyrazol-3-yl)methyl)thio)-5-alkyl-6-(cyclohexylmethyl)-pyrimidin-4(3)-ones as potential HIV-1 inhibitors.

Yumeng WU ; Chengrun TANG ; Ruomei RUI ; Liumeng YANG ; Wei DING ; Jiangyuan WANG ; Yiming LI ; Christopher C LAI ; Yueping WANG ; Ronghua LUO ; Weilie XIAO ; Hongbing ZHANG ; Yongtang ZHENG ; Yanping HE

Acta Pharmaceutica Sinica B 2020;10(3):512-528

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 7 , 1/1 Show Home Prev Next End page: GO